Related Experiment Video
Updated: Apr 19, 2026
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
9.0K
Baseline blood eosinophil count does not predict short-term changes in oscillometric psarameters in steroid-naïve
1Department of Allergy and Rheumatology, Osaka Habikino Medical Center, Habikino, Ōsaka, Japan.
Summary
Peripheral blood eosinophil counts do not predict early airway mechanics changes in steroid-naïve asthma patients treated with inhaled corticosteroids. Oscillometry results were similar regardless of baseline eosinophil levels, suggesting limited predictive value for this biomarker.
Area of Science:
- Pulmonary Medicine
- Respiratory Research
- Clinical Immunology
Background:
- Peripheral blood eosinophil (PBE) count is a key biomarker for asthma treatment decisions.
- The predictive value of PBE for early airway mechanics changes via oscillometry in steroid-naïve asthma is not well-established.
Purpose of the Study:
- To investigate the association between baseline PBE levels and early changes in oscillometric indices of airway function.
- To assess if PBE count predicts treatment response in steroid-naïve asthma patients receiving inhaled corticosteroids.
Main Methods:
- Retrospective analysis of 57 adult steroid-naïve asthma patients.
- Comparison of oscillometric parameters (R5, R20, R5-R20, X5, Fres, ALX) before and after 12 weeks of inhaled corticosteroid therapy.
- Stratification of patients based on baseline PBE count (≥300 vs <300 cells/μL).
Main Results:
- No significant differences in percentage changes of oscillometric parameters were found between high and low PBE groups.
- Effect sizes for group differences were small, with confidence intervals crossing zero.
- Baseline PBE count did not show a clinically meaningful association with early oscillometric improvement.
Conclusions:
- Baseline PBE count is not a reliable predictor of early changes in oscillometric indices in steroid-naïve asthma.
- PBE may be more relevant for predicting spirometric responses than oscillometric changes.
- Spirometry and oscillometry offer complementary information for assessing early asthma treatment responses.
Related Concept Videos
01:28Asthma I: Introduction
3
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
3
01:30Asthma-IV: Diagnostic and Management
3.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:26Asthma-II: Pathophysiology and Classification
5.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
01:13Asthma III: Clinical Manifestations
16
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
16
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K